Litcius/Paper detail

The Role of Peroxisome Proliferator-Activated Receptors in Kidney Diseases

Jianjun Gao, Zhaoyan Gu

2022Frontiers in Pharmacology71 citationsDOIOpen Access PDF

Abstract

Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear hormone receptor superfamily of ligand-activated transcription factors. Accumulating evidence suggests that PPARs may play an important role in the pathogenesis of kidney disease. All three members of the PPAR subfamily, PPARα, PPARβ/δ, and PPARγ, have been implicated in many renal pathophysiological conditions, including acute kidney injury, diabetic nephropathy, and chronic kidney disease, among others. Emerging data suggest that PPARs may be potential therapeutic targets for renal disease. This article reviews the physiological roles of PPARs in the kidney and discusses the therapeutic utility of PPAR agonists in the treatment of kidney disease.

Topics & Concepts

Peroxisome proliferator-activated receptorNuclear receptorKidney diseaseReceptorKidneyTranscription factorDiabetic nephropathyPathogenesisMedicinePeroxisome proliferatorBiologyInternal medicineBioinformaticsEndocrinologyGeneBiochemistryPeroxisome Proliferator-Activated ReceptorsLiver Disease Diagnosis and TreatmentMetabolism, Diabetes, and Cancer
The Role of Peroxisome Proliferator-Activated Receptors in Kidney Diseases | Litcius